Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by SUVARI TRICIA BORGA. Officer active across 1 company, notably Global Blood Therapeutics, Inc.. Cumulatively, 12 disclosures have been published. Activity tracked since 31 August 2021. The latest transaction was disclosed on 31 August 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations12 total
43,077 sharesCommon StockSEC:0000899243-22-033144:0
385 shares@ US$25.3744.7% of flowCommon StockSEC:0000899243-22-030473:0
6,145 sharesCommon StockSEC:0000899243-22-027639:0
453 shares@ US$25.3785.3% of flowCommon StockSEC:0000899243-22-009256:0
9,395 sharesCommon StockSEC:0000899243-22-004650:0
9,395 sharesCommon StockSEC:0000899243-22-004650
9,395 sharesCommon StockSEC:0000899243-21-037665:0
9,395 sharesCommon StockSEC:0000899243-21-037665
43 shares@ US$24.394.1% of flowCommon StockSEC:0000899243-21-035222
43 shares@ US$24.397.4% of flowCommon StockSEC:0000899243-21-035222:0
9,395 sharesCommon StockSEC:0000899243-21-031342
9,395 sharesCommon StockSEC:0000899243-21-031342:0
About SUVARI TRICIA BORGA
Tricia Borga Suvari is a director at Global Blood Therapeutics, Inc.